Sun Pharma & Bayer tie up to market new renal therapy

Sun Pharma and Bayer have entered into an agreement to market and distribute a second brand of the patented medicine Finerenone in India. Finerenone is designed to reduce the risk of various complications in adult patients with chronic kidney disease associated with type 2 diabetes mellitus. Under the deal, Bayer has granted...